Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-13

Clinical Trial Update: Transdermal Testosterone for Poor Responder Patients Undergoing Controlled Ovarian Stimulation Prior to IVF [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating transdermal testosterone to improve ovarian stimulation outcomes in poor responders undergoing IVF.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transdermal Testosterone (testosterone)

Snippet

Sponsor: Wolfson Medical Center | Conditions: Infertility, Female | Phase 4 | Status: UNKNOWN